• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pentokey Organy (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2366.0
  • ISIN : INE702E01015
36.14 -2 (-4.97%)
  • As on 02 Aug 2025 (EOD)
  • Today’s Low

    35.51
  • Today’s High

    38.03
  • Open

    38.03
  • Perv Close

    38.03
  • 52W Low

    27.50
  • 52W High

    64.50

Key Indicators

  • P/E(TTM)

    92.67

  • Mar.Cap (₹Cr.)

    22.66

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.07

  • Debt-Equity Ratio

    -4.97

  • AGM Date

    01-Aug-2025

  • EPS

    0.39

  • P/E Ratio

    92.67

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    22.66

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.27

  • BV (₹)

    15.10

  • Sales( ₹ in Cr.)

    0.83

  • NP (in Cr.)

    0.25

  • NP Var(%)

    -72.0

  • Div%

    0.0

  • CPS (₹)

    0.40

  • EPS (₹)

    0.40

  • Traded Value (₹ in Lakhs)

    22.66

  • 52 Week High

    64.50

  • 52 Week Low

    27.50

  • Price BSE

    36.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    22.66

  • P/C Ratio

    91.80

  • P/E Ratio

    91.90

  • Price Vs.BV

    0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 4.40 4.37 0.00 0.00 1.56 9.29
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4.40 4.37 0.00 0.00 1.56 9.29
Other Income 0.45 2.36 0.25 0.30 0.25 1.17
Stock Adjustments -0.21 0.21 0.00 0.00 -0.28 0.28
Total Income 4.64 6.94 0.25 0.30 1.53 10.74
EXPENDITURE :            
Raw Materials 3.25 3.41 0.00 0.00 1.21 9.49
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.14 0.14 0.18 0.21 0.19 0.19
Other Manufacturing Expenses 0.16 0.00 0.00 0.00 0.00 0.02
Selling and Administration Expenses 0.18 0.15 0.20 0.28 0.40 0.50
Miscellaneous Expenses 0.03 0.02 0.03 0.04 0.16 0.17
Employee Benefit Expenses 0.14 0.14 0.18 0.21 0.19 0.19
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 3.76 3.72 0.41 0.54 1.97 10.38
Operating Profit 0.89 3.21 -0.16 -0.24 -0.44 0.36
Interest 0.01 0.03 0.00 0.00 0.00 0.05
Gross Profit 0.88 3.18 -0.16 -0.24 -0.44 0.31
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 0.88 3.18 -0.16 -0.24 -0.44 0.31
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.87 3.18 -0.16 -0.24 -0.44 0.31
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.97
Adjusted Net Profit 0.87 3.18 -0.16 -0.24 -0.44 -0.66
Adjustment below Net Profit 0.01 0.00 0.01 0.01 -0.01 0.00
P & L Balance brought forward 1.63 -1.54 -1.39 -1.15 -0.71 -1.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 2.52 1.63 -1.54 -1.39 -1.15 -0.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.39 5.06 -0.26 -0.38 -0.70 0.50
Earnings Per Share(Adj)-Unit Curr 1.39 5.06 -0.26 -0.38 -0.70 0.50
Book Value 14.77 13.36 8.29 8.54 8.91 9.63
Book Value(Adj)-Unit Curr 14.77 13.36 8.29 8.54 8.91 9.63

Shareholding Pattern

  • Promoter Group

    73.03%

  • Public Share Holding

    26.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,581,209 73.03 4,570,959 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,581,209 73.03 4,570,959 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 4,000 0.06 4,000 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 140,817 2.24 140,817 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 144,817 2.31 144,817 2
2] Non Institution
Bodies Corporate 15,471 0.25 10,254 38
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 648 0.01 648 13
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 180,388 2.88 180,388 4
Individuals holding nominal share capital up to Rs. 1 lakh 842,557 13.43 452,114 9,169
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 507,539 8.09 507,246 34
Sub Total 1,546,603 24.66 1,150,650 9,258
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,272,629 100.00 5,866,426 9,265

Company Background

Pentokey Organy (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Pentokey Organy (India) Ltd
  • BSE Code : 2366.0
  • ISIN : INE702E01015
  • Incorporation Year

    1986

  • Registered Office

    509 Western Edge I Western edg
    Express Highway warehouse, Mumbai,
    Maharashtra-400066

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    Verma Mehta & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Datamatics Financial Services
    Plot No B-5 MIDC ,
    Part B Cross Lane ,Marol Andheri(E)
    Mumbai - Mumbai-400093

Pentokey Organy (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pentokey Organy 36.14 4.85 4.40 92.67 9.98
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10